Literature DB >> 9061001

Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen.

K Hashimoto1, M Noshiro, S Ohno, T Kawamoto, H Satakeda, Y Akagawa, K Nakashima, A Okimura, H Ishida, T Okamoto, H Pan, M Shen, W Yan, Y Kato.   

Abstract

A 66-kDa collagen fiber-associated protein (RGD-CAP) was isolated from a fiber-rich fraction of pig cartilage by ultrafiltration and collagen-affinity chromatography. Amino acid sequencing and cDNA cloning indicated that the RGD-CAP is identical or closely related to beta ig-h3 protein which is induced in human adenocarcinoma cells by transforming growth factor-beta (TGF-beta) (Skonier, J., Neubauer, M., Madisen, L., Bennett, K., Plowman, G.D., and Purchio, A.F. (1992) DNA Cell. Biol. 11, 511-522). The RGD-CAP, as well as beta ig-h3, has the RGD sequence in the C-terminal region. The native RGD-CAP bound to type I, II, and IV collagens even in the presence of 1 M NaCl. A recombinant preparation of RGD-CAP expressed in Escherichia coli cells also bound to collagen but not to gelatin. The RGD-CAP mRNA was expressed in chondrocytes throughout all stages, although the expression level was highest during the prehypertrophic stage. In addition, TGF-beta increased the RGD-CAP mRNA level in chondrocyte cultures. Since RGD-CAP transcripts were found in most tissues, this novel collagen-binding protein may play an important role in cell-collagen interactions in various tissues including developing cartilage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9061001     DOI: 10.1016/s0167-4889(96)00147-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  51 in total

1.  A migration signature and plasma biomarker panel for pancreatic adenocarcinoma.

Authors:  Seetharaman Balasenthil; Nanyue Chen; Steven T Lott; Jinyun Chen; Jennifer Carter; William E Grizzle; Marsha L Frazier; Subrata Sen; Ann McNeill Killary
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-11

Review 2.  Periostin function in communication with extracellular matrices.

Authors:  Akira Kudo; Isao Kii
Journal:  J Cell Commun Signal       Date:  2017-10-30       Impact factor: 5.782

3.  Proteomic analysis profile of engineered articular cartilage with chondrogenic differentiated adipose tissue-derived stem cells loaded polyglycolic acid mesh for weight-bearing area defect repair.

Authors:  Lunli Gong; Xiao Zhou; Yaohao Wu; Yun Zhang; Chen Wang; Heng Zhou; Fangfang Guo; Lei Cui
Journal:  Tissue Eng Part A       Date:  2013-11-14       Impact factor: 3.845

4.  Comparative proteomic analysis of normal and collagen IX null mouse cartilage reveals altered extracellular matrix composition and novel components of the collagen IX interactome.

Authors:  Bent Brachvogel; Frank Zaucke; Keyur Dave; Emma L Norris; Jacek Stermann; Münire Dayakli; Manuel Koch; Jeffrey J Gorman; John F Bateman; Richard Wilson
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

5.  Differential expression and processing of transforming growth factor beta induced protein (TGFBIp) in the normal human cornea during postnatal development and aging.

Authors:  Henrik Karring; Kasper Runager; Zuzana Valnickova; Ida B Thøgersen; Torben Møller-Pedersen; Gordon K Klintworth; Jan J Enghild
Journal:  Exp Eye Res       Date:  2009-09-26       Impact factor: 3.467

6.  Defining elastic fiber interactions by molecular fishing: an affinity purification and mass spectrometry approach.

Authors:  Stuart A Cain; Amanda McGovern; Elaine Small; Lyle J Ward; Clair Baldock; Adrian Shuttleworth; Cay M Kielty
Journal:  Mol Cell Proteomics       Date:  2009-09-15       Impact factor: 5.911

7.  Expression of migration-related genes is progressively upregulated in murine Lineage-Sca-1+c-Kit+ population from the fetal to adult stages of development.

Authors:  Jesús Ciriza; Marcos E García-Ojeda
Journal:  Stem Cell Res Ther       Date:  2010-05-20       Impact factor: 6.832

8.  Proteomic profiling of TGFBI-null mouse corneas reveals only minor changes in matrix composition supportive of TGFBI knockdown as therapy against TGFBI-linked corneal dystrophies.

Authors:  Ebbe Toftgaard Poulsen; Kasper Runager; Nadia Sukusu Nielsen; Marie V Lukassen; Karen Thomsen; Paige Snider; Olga Simmons; Henrik Vorum; Simon J Conway; Jan J Enghild
Journal:  FEBS J       Date:  2017-11-23       Impact factor: 5.542

9.  Evidence against a blood derived origin for transforming growth factor beta induced protein in corneal disorders caused by mutations in the TGFBI gene.

Authors:  Henrik Karring; Zuzana Valnickova; Ida B Thøgersen; Chris J Hedegaard; Torben Møller-Pedersen; Torsten Kristensen; Gordon K Klintworth; Jan J Enghild
Journal:  Mol Vis       Date:  2007-06-27       Impact factor: 2.367

10.  Denaturation and solvent effect on the conformation and fibril formation of TGFBIp.

Authors:  Heather L Grothe; Morgan R Little; Angela S Cho; Andrew J W Huang; Ching Yuan
Journal:  Mol Vis       Date:  2009-12-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.